1 terminated. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Terminated 1 |
Follow Pe: new trials by email Literature Review of Pe trials Research Report on Pe
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study With Imlifidase in Anti-GBM Disease Imlifidase, Plasma exchange (PLEX), Cyclophosphamide (CYC) - Anti-Glomerular Basement Membrane Disease, Anti-Glomerular Basement Membrane Antibody Disease | Phase 3 | Terminated | Hansa Biopharma AB | 50 | 2022-12-22 | 2026-03-04 |
Anti-Glomerular Basement Membrane Disease (1) · Rapidly progressive glomerulonephritis with pulmonary hemorrhage (1)
Austria (1) · Belgium (1) · Czechia (1) · Denmark (1) · France (1) · Germany (1) · Ireland (1) · Italy (1) · Netherlands (1) · Spain (1) · Sweden (1) · United Kingdom (1) · United States (1)